ARROWHEAD PHARMACEUTICALS: UK NICE RECOMMENDS NHS FUNDING FOR REDEMPLO (PLOZASIRAN) FOR GENETICALLY CONFIRMED FCS IN ADULTS

Reuters · 3d ago

Please log in to view news